Skip to main content
. 2020 Jul 22;19(3):233–239. doi: 10.4103/wjnm.WJNM_71_19

Table 1.

Characteristics of all the patients (a) in association with 18F-fluoroestradiol positron emission tomography findings and (b) in association with 5-flurodeoxy glucose positron emission tomography findings

a. FES PET CT findings

Patient number Age Sex ER SUV of breast lump SUV I/L LN SUV C/L LN SUV IM LN SUV metastasis Site of metastasis MBP Tumor-to- background ratio
1 47 Female 0 10 8.67 4.17 2.65 3.77
2 40 Female 0 15.04 16.20 1.39 3.45 1.33 11.30
3 43 Female 0 13.5 11.20 4.5 4.95 Bone 4.5 3
4 56 Female 0 26.72 25.50 3.28 8.14
5 46 Female 0
6 48 Female 0 19.2 27.54 5.86 1.223 15.69
7 62 Female 0 12.73 12.80 2.87 Lung 3.4 3.74
8 83 Female 3 25.4 26.50 11.7 14.3 5.4/13.6/17.8 D11/abd LN/liver lesion 2 12.70
9 58 Female 6 52.8 10.84 19.22 Right supraclavicular 2.58 20.46
10 40 Female 7 9.09 1.10 3.33 2.72
11 51 Female 7
12 32 Female 8 6.21 3.93 3.27 2.19 2.83
13 50 Female 8
14 55 Female 8
15 60 Female 8 9.06 2.48 3.2 2.83
16 46 Female 8
17 55 Female 8 2.8 0.80 1.54 1.81
18 65 Female 8 39.7 7.80 3.9 10.17
19 65 Female 8 9.5 1.70 1.2 7.91
20 72 Male 8 26.01 4.30 11.49 Prevascular LN 1.42 18.31
21 56 Male 8
22 60 Female 8 7.83 6.76 1.13 6.92
23 60 Female 0 31.93 35.54 8.97 25.97 1.6 19.95

b. FDG PET CT findings

Patient Age Sex ER SUV tumor SUV I/L LN SUV C/L LN SUV IN LN SUV metastasis Site of metastasis MBP Tumor-to- background ratio Visual interpretation grading
1 47 Female 0 1.55 1.04 00.5 1.49 3.77 1
2 40 Female 0 1.22 0.76 00.73 1.22 11.30 1
3 43 Female 0 1.8 1.5 11.18 0.79 Bone 2 3 2
4 56 Female 0 1.58 1.7 2.01 8.14 2
5 46 Female 0 0.97 0.62 0.61 1
6 48 Female 0 1.15 1.13 1.26 1.6 15.69 2
7 62 Female 0 1.85 1.68 2.95 Lung 2.39 3.74 1
8 83 Female 3 1.9 1.6 11.1 0.9 1.7/2.9 D11/abd LN/liver lesion no comment 2.1 12.70 2
9 58 Female 6 1.74 1.1 1.45 Right supraclavicular 1.4 20.46 3
10 40 Female 7 1.34 0.88 2.08 2.72 1
11 51 Female 7 5.88 1.31 1.73 4
12 32 Female 8 3.81 4.12 3.72 1.67 2.83 4
13 50 Female 8 1.05 0.63 4
14 55 Female 8 0.55 1.43 1
15 60 Female 8 5.84 10.1 1.3 2.83 4
16 46 Female 8 3.38 1.39 1.01 4
17 55 Female 8 3.93 1.33 1.13 1.81 4
18 65 Female 8 2.1 0.1 0.37 10.17 4
19 65 Female 8 3.03 0.69 7.91 4
20 72 Male 8 5.78 1.4 1.48 Prevascular LN 1.53 18.31 4
21 56 Male 8 8.02 1.21 4
22 60 Female 8 23.04 18.69 1.74 6.92 4
23 60 Female 0 1.23 1.56 11.08 0.64 0.9 Lung 1.5 19.95 1

SUV: Standardized uptake value; LN: Lymph node; I/L LN: Ipsilateral LN; C/L LN: Contralateral LN; ER: Estrogen receptor; FDG: 5-flurodeoxyglucose; PET: Positron emission tomography; CT: Computed tomography; IM: Internal mammary; FES: 18F-fluoroestradiol; MBP: Medistinal blood pool, abd: Abdomen